Franco EL

Idioma: Ingles.
Referencias bibliográficas: 11
Paginas: 609-611
Archivo PDF: 295.11 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Carvalho MRC, Franco EL. Cancer Incidence in Recife, Brazil. In: Franco EL (ed). LICR Monograph Series in Cancer Epidemiology, Vol. 2. Sao Paulo: Ludwig Institute for Cancer Research, 1986.

2. Brumini R (ed). Cancer in Brazil: histopathological data. Rio de Janeiro: Ministry of Health, 1982.

3. Franco EL, Campos Filho N, Villa LL, Torloni H. Correlation patterns of cancer relative frequencies with some socioeconomic and demographic indicators in Brazil: an ecologic study. Int J Cancer. 1988;41(1):24-9. https:// doi.org/10.1002/ijc.2910410106

4. Dürst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA. 1983;80(12):3812-5. https://doi.org/10.1073/pnas.80.12.3812

5. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol. 1976;20(6):505-9.

6. Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, et al. Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study. Salud Publica Mex. 2016;58(2):197-210. https://doi.org/10.21149/spm.v58i2.7789

7. Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, et al. Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. J Natl Cancer Inst. 2018;110(2). https://doi.org/10.1093/ jnci/djx158

8. Wittet S. Target: elimination of cervical cancer. PATH, 2018 [cited 2018 Sep 20]. Available from: https://www.path.org/articles/target-eliminationcervical- cancer/

9. Franco EL, Tsu V, Herrero R, Lazcano-Ponce E, Hildesheim A, Muñoz N, et al. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine. 2008;26(suppl 11):L88-95. https://doi.org/10.1016/j.vaccine.2008.05.026

10. Wittet S. The Cost of Cervical Cancer Prevention in Low- and Lower- Middle-Income Countries. Cervical Cancer Action [cited 2018 Sep 20]. Available from: http://cervicalcanceraction.org/pubs/CCA_cost_modeling_ brief_2017.pdf

11. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica. 1999;6(4):223-33. https://doi.org/10.1590/S1020-49891999000900001